293 related articles for article (PubMed ID: 22072427)
41. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications.
Cabrera-Pastor A; Llansola M; Montoliu C; Malaguarnera M; Balzano T; Taoro-Gonzalez L; García-García R; Mangas-Losada A; Izquierdo-Altarejos P; Arenas YM; Leone P; Felipo V
Acta Physiol (Oxf); 2019 Jun; 226(2):e13270. PubMed ID: 30830722
[TBL] [Abstract][Full Text] [Related]
42. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
Montagnese S; Biancardi A; Schiff S; Carraro P; Carlà V; Mannaioni G; Moroni F; Tono N; Angeli P; Gatta A; Amodio P
Hepatology; 2011 Feb; 53(2):558-66. PubMed ID: 21274876
[TBL] [Abstract][Full Text] [Related]
43. Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.
Senzolo M; Zarantonello L; Formentin C; Orlando C; Beltrame R; Vuerich A; Angeli P; Burra P; Montagnese S
Metab Brain Dis; 2019 Dec; 34(6):1803-1812. PubMed ID: 31506797
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
45. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
[TBL] [Abstract][Full Text] [Related]
46. Hepatic Encephalopathy Is Reversible in the Long Term After Liver Transplantation.
Hopp AE; Dirks M; Petrusch C; Goldbecker A; Tryc AB; Barg-Hock H; Strassburg C; Klempnauer J; Weissenborn K; Pflugrad H
Liver Transpl; 2019 Nov; 25(11):1661-1672. PubMed ID: 31437344
[TBL] [Abstract][Full Text] [Related]
47. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.
Mani AR; Montagnese S; Jackson CD; Jenkins CW; Head IM; Stephens RC; Moore KP; Morgan MY
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G330-8. PubMed ID: 19023029
[TBL] [Abstract][Full Text] [Related]
48. Extracellular Vesicles From Hyperammonemic Rats Induce Neuroinflammation in Cerebellum of Normal Rats: Role of Increased TNFα Content.
Izquierdo-Altarejos P; Martínez-García M; Felipo V
Front Immunol; 2022; 13():921947. PubMed ID: 35911759
[TBL] [Abstract][Full Text] [Related]
49. Urea cycle dysregulation in non-alcoholic fatty liver disease.
De Chiara F; Heebøll S; Marrone G; Montoliu C; Hamilton-Dutoit S; Ferrandez A; Andreola F; Rombouts K; Grønbæk H; Felipo V; Gracia-Sancho J; Mookerjee RP; Vilstrup H; Jalan R; Thomsen KL
J Hepatol; 2018 Oct; 69(4):905-915. PubMed ID: 29981428
[TBL] [Abstract][Full Text] [Related]
50. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.
Iwasa M; Sugimoto R; Mifuji-Moroka R; Hara N; Yoshikawa K; Tanaka H; Eguchi A; Yamamoto N; Sugimoto K; Kobayashi Y; Hasegawa H; Takei Y
Metab Brain Dis; 2016 Oct; 31(5):1151-6. PubMed ID: 27353278
[TBL] [Abstract][Full Text] [Related]
51. Amelioration of Hepatic Encephalopathy Using
El-Baz FK; Elgohary R; Salama A
Biomed Res Int; 2021; 2021():8843218. PubMed ID: 33855084
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy.
Schulz C; Schütte K; Reisener N; Voss J; Malfertheiner P
J Gastrointestin Liver Dis; 2016 Jun; 25(2):191-5. PubMed ID: 27308650
[TBL] [Abstract][Full Text] [Related]
53. Hepatic encephalopathy, hyperammonemia, and ammonia toxicity. Papers presented at the International Symposium on Cirrhosis, Hyperammonemia and hepatic encephalopathy. Valencia, Spain, January 24-27, 1994.
Adv Exp Med Biol; 1994; 368():1-205. PubMed ID: 7740999
[No Abstract] [Full Text] [Related]
54. Gut ammonia production and its modulation.
Romero-Gómez M; Jover M; Galán JJ; Ruiz A
Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141
[TBL] [Abstract][Full Text] [Related]
55. Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism.
Díaz-Fontenla F; Castillo-Pradillo M; Díaz-Gómez A; Ibañez-Samaniego L; Gancedo P; Guzmán-de-Villoria JA; Fernández-García P; Bañares-Cañizares R; García-Martínez R
World J Gastroenterol; 2017 Jul; 23(28):5246-5252. PubMed ID: 28811719
[TBL] [Abstract][Full Text] [Related]
56. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.
Wunsch E; Koziarska D; Milkiewicz M; Naprawa G; Nowacki P; Hartleb M; Milkiewicz P
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1402-7. PubMed ID: 24025977
[TBL] [Abstract][Full Text] [Related]
57. Impact of family history of metabolic traits on severity of non-alcoholic steatohepatitis related cirrhosis: A cross-sectional study.
Bhadoria AS; Kedarisetty CK; Bihari C; Kumar G; Jindal A; Bhardwaj A; Shasthry V; Vyas T; Benjamin J; Sharma S; Sharma MK; Sarin SK
Liver Int; 2017 Sep; 37(9):1397-1404. PubMed ID: 28231412
[TBL] [Abstract][Full Text] [Related]
58. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
Blanco Vela CI; Poo Ramírez JL
Ann Hepatol; 2011 Jun; 10 Suppl 2():S55-9. PubMed ID: 22228883
[TBL] [Abstract][Full Text] [Related]
60. Magnesium Deficiency and Minimal Hepatic Encephalopathy among Patients with Compensated Liver Cirrhosis.
Cohen-Hagai K; Feldman D; Turani-Feldman T; Hadary R; Lotan S; Kitay-Cohen Y
Isr Med Assoc J; 2018 Sep; 20(9):533-538. PubMed ID: 30221864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
